233 related articles for article (PubMed ID: 32654378)
1. SARS-CoV-2: An immunogenetics call to arms.
Clark B; Poulton K
Int J Immunogenet; 2020 Aug; 47(4):319-323. PubMed ID: 32654378
[TBL] [Abstract][Full Text] [Related]
2. Covid-19: Perspectives on Innate Immune Evasion.
Taefehshokr N; Taefehshokr S; Hemmat N; Heit B
Front Immunol; 2020; 11():580641. PubMed ID: 33101306
[TBL] [Abstract][Full Text] [Related]
3. The COVID-19 Cytokine Storm; What We Know So Far.
Ragab D; Salah Eldin H; Taeimah M; Khattab R; Salem R
Front Immunol; 2020; 11():1446. PubMed ID: 32612617
[TBL] [Abstract][Full Text] [Related]
4. Targeting innate immunity by blocking CD14: Novel approach to control inflammation and organ dysfunction in COVID-19 illness.
Martin TR; Wurfel MM; Zanoni I; Ulevitch R
EBioMedicine; 2020 Jul; 57():102836. PubMed ID: 32574958
[TBL] [Abstract][Full Text] [Related]
5. After 62 years of regulating immunity, dexamethasone meets COVID-19.
Cain DW; Cidlowski JA
Nat Rev Immunol; 2020 Oct; 20(10):587-588. PubMed ID: 32778829
[TBL] [Abstract][Full Text] [Related]
6. Leukoerythroblastosis and plasmacytoid lymphocytes in a child with SARS-CoV-2-associated multisystem inflammatory syndrome.
Lee WS; Margolskee E
Blood; 2020 Aug; 136(7):914. PubMed ID: 32790856
[No Abstract] [Full Text] [Related]
7. The many faces of the anti-COVID immune response.
Vardhana SA; Wolchok JD
J Exp Med; 2020 Jun; 217(6):. PubMed ID: 32353870
[TBL] [Abstract][Full Text] [Related]
8. Potential Treatments for COVID-19 Related Cytokine Storm - Beyond Corticosteroids.
Miao Y; Fan L; Li JY
Front Immunol; 2020; 11():1445. PubMed ID: 32612616
[No Abstract] [Full Text] [Related]
9. Surviving the storm: Dealing with COVID-19.
Vandenbark AA; Meza-Romero R; Offner H
Cell Immunol; 2020 Aug; 354():104153. PubMed ID: 32563849
[No Abstract] [Full Text] [Related]
10. SARS-CoV-2 infection-induced immune responses: Friends or foes?
Li K; Hao Z; Zhao X; Du J; Zhou Y
Scand J Immunol; 2020 Aug; 92(2):e12895. PubMed ID: 32445403
[TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2 infection: The role of cytokines in COVID-19 disease.
Costela-Ruiz VJ; Illescas-Montes R; Puerta-Puerta JM; Ruiz C; Melguizo-RodrÃguez L
Cytokine Growth Factor Rev; 2020 Aug; 54():62-75. PubMed ID: 32513566
[TBL] [Abstract][Full Text] [Related]
12. Cytokine storm intervention in the early stages of COVID-19 pneumonia.
Sun X; Wang T; Cai D; Hu Z; Chen J; Liao H; Zhi L; Wei H; Zhang Z; Qiu Y; Wang J; Wang A
Cytokine Growth Factor Rev; 2020 Jun; 53():38-42. PubMed ID: 32360420
[TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2 triggers inflammatory responses and cell death through caspase-8 activation.
Li S; Zhang Y; Guan Z; Li H; Ye M; Chen X; Shen J; Zhou Y; Shi ZL; Zhou P; Peng K
Signal Transduct Target Ther; 2020 Oct; 5(1):235. PubMed ID: 33037188
[TBL] [Abstract][Full Text] [Related]
14. Cytokine Release Syndrome in COVID-19 Patients, A New Scenario for an Old Concern: The Fragile Balance between Infections and Autoimmunity.
Picchianti Diamanti A; Rosado MM; Pioli C; Sesti G; Laganà B
Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32397174
[TBL] [Abstract][Full Text] [Related]
15. Lessons from dermatology about inflammatory responses in Covid-19.
Criado PR; Pagliari C; Carneiro FRO; Quaresma JAS
Rev Med Virol; 2020 Sep; 30(5):e2130. PubMed ID: 32656939
[TBL] [Abstract][Full Text] [Related]
16. Targeting T-cell senescence and cytokine storm with rapamycin to prevent severe progression in COVID-19.
Omarjee L; Janin A; Perrot F; Laviolle B; Meilhac O; Mahe G
Clin Immunol; 2020 Jul; 216():108464. PubMed ID: 32405269
[No Abstract] [Full Text] [Related]
17. The Comparative Immunological Characteristics of SARS-CoV, MERS-CoV, and SARS-CoV-2 Coronavirus Infections.
Zhang YY; Li BR; Ning BT
Front Immunol; 2020; 11():2033. PubMed ID: 32922406
[TBL] [Abstract][Full Text] [Related]
18. Cytokine Storms: Understanding COVID-19.
Mangalmurti N; Hunter CA
Immunity; 2020 Jul; 53(1):19-25. PubMed ID: 32610079
[TBL] [Abstract][Full Text] [Related]
19. Pro- and Anti-Inflammatory Responses in Severe COVID-19-Induced Acute Respiratory Distress Syndrome-An Observational Pilot Study.
Notz Q; Schmalzing M; Wedekink F; Schlesinger T; Gernert M; Herrmann J; Sorger L; Weismann D; Schmid B; Sitter M; Schlegel N; Kranke P; Wischhusen J; Meybohm P; Lotz C
Front Immunol; 2020; 11():581338. PubMed ID: 33123167
[TBL] [Abstract][Full Text] [Related]
20. IL-6: Relevance for immunopathology of SARS-CoV-2.
Gubernatorova EO; Gorshkova EA; Polinova AI; Drutskaya MS
Cytokine Growth Factor Rev; 2020 Jun; 53():13-24. PubMed ID: 32475759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
